Stocktoria
HARVARD BIOSCIENCE INC HBIO
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2013-10-21
HARVARD BIOSCIENCE INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Gross margin | 57.7% | — | 58.2% | 58.9% | 53.7% |
| Operating margin | -56.1% | — | -6.6% | 1.7% | -6.1% |
| Net margin | -65.5% | — | -13.2% | -3.0% | -8.4% |
| FCF margin | 6.3% | — | -1.3% | 10.9% | -0.4% |
| Return on assets | -70.8% | -15.9% | -9.8% | -2.5% | -6.5% |
| Return on equity | -412.8% | -88.3% | -19.6% | -4.7% | -13.2% |
| Debt / equity | 2.61× | 2.41× | 0.58× | 0.51× | 0.65× |
| Current ratio | 2.20 | 0.81 | 0.82 | 1.85 | 2.20 |
| Revenue growth | — | — | -16.1% | -1.0% | -4.7% |
Source: SEC EDGAR filings · CIK 0001123494 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.